COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 37: Articles 361-370  | Next

Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up
Alves, K., Kotloff, K. L., McClelland, R. S., Hammershaimb, E. A., Kouassi, A., Plested, J. S., Kalkeri, R., Zhu, M., Cloney-Clark, S., Cai, Z., Smith, K., Kaba, M., Nelson, J., Mallory, R. M., Noriega, F.
10.1101/2025.04.09.25325550 — Posted: 2025-04-10
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection
Nooruzzaman, M., Butt, S. L., Rani, R., Ye, C., Martinez-Sobrido, L., Fang, Y., Diel, D. G.
10.1101/2025.04.09.647941 — Posted: 2025-04-10
Reconstructing the force of infection and immune fraction of the population via a single snapshot survey: a case study of COVID-19 in Japan
Okada, Y., Nishiura, H.
10.1101/2025.04.08.25325449 — Posted: 2025-04-09
Bayesian automatic screening of pneumoniaand lung lesions localization from CT scans. Acombined method toward a more user-centredand explainable approach
Moure Prado, A., Guerrero-Lopez, A., Arias-Londono, J. D., Godino-Llorente, J. I.
10.1101/2025.04.08.647710 — Posted: 2025-04-09
Mutations differentially affecting the coronavirus Mac1 ADP-ribose binding and hydrolysis activities indicate that it promotes multiple stages of the viral replication cycle
O Connor, J., Roy, A., Khattabi, R., Kerr, C. M., Schwarting, N., Alhammad, Y. M., Gao, P., Zhang, X., Deng, X., Fehr, A. R.
10.1101/2025.04.08.647734 — Posted: 2025-04-09
Transient, early, female-specific increase in cortical glial fibrillary acidic protein distribution in the Syrian hamster model of mild peripheral COVID-19
Rahmani Manesh, M., Wicki-Stordeur, L. E., York, N. S., Vendramelli, R., Warner, B., Vecchiarelli, H. A., Ranier-Pope, L., Khakpour, M., Bennouna, L. R., Tremblay, M.-E., Kobasa, D., Swayne, L. A.
10.1101/2025.04.08.647811 — Posted: 2025-04-09
Brainstem Reduction and Deformation in the 4th Ventricle Cerebellar Peduncles in Long COVID Patients: Insights into Neuroinflammatory Sequelae and "Broken Bridge Syndrome"
Ziaja, C. P., Young, S. Y., Stark Sadre-Chirazi, M., Lindner, T., Zurek, G., Sedlacik, J.
10.1101/2025.04.08.25325108 — Posted: 2025-04-08
Differential association of SARS-CoV-2 IgG responses with anti-OC43 IgG in a Senegalese cohort
Faye, R., Mbow, A. A., Tall, B., Gaye, A., Ndoye, A. M., Gueye, R., Diallo, D., Faye, F. N., Talla, C., Dia, N., Mbengue, B., Pelleau, S., Niang, M., Seydi, M., Sall, A. A., Taïeb, F., Loucoubar, C., White, M., Poiret, T., Vigan-Womas, I.
10.1101/2025.04.07.647508 — Posted: 2025-04-08
Characteristics of patients with pneumonia caused by SARS-Cov-2
Ngo, H. T., Nguyen, C. D., Pham, T. M., Phung, M. T., Hoang, D. T., Do, S. T., Le, D. T., Bui, Q., Nguyen, T., Le, T. D., Le, M. H. N.
10.1101/2025.04.06.25325329 — Posted: 2025-04-08
1st, 2nd, and 3rd+ SARS-CoV-2 infections: associations of prior infections with protection and severity
Maier, H. E., Ojeda, S., Shotwell, A., Lopez, R., Sanchez, N., Saborio, S., Plazaola, M., Barilla, C., Kuan, G., Balmaseda, A., Gordon, A.
10.1101/2025.04.07.25324191 — Posted: 2025-04-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).